Commissioner’s National Priority Voucher (CNPV) Pilot Program Public Hearing
U.S. Food and Drug Administration (FDA) · June 4, 2026
The FDA held a Part 15 public meeting to solicit stakeholder feedback on the Commissioner's National Priority Voucher (CNPV) Pilot Program, hearing from agency officials, industry, patient advocates, clinicians, and public interest groups about program design, selection criteria, transparency, resourcing, and patient impacts; the docket remains open through June 29 for written comments.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.